243 related articles for article (PubMed ID: 18343947)
1. CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.
Holtappels R; Böhm V; Podlech J; Reddehase MJ
Med Microbiol Immunol; 2008 Jun; 197(2):125-34. PubMed ID: 18343947
[TBL] [Abstract][Full Text] [Related]
2. Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.
Böhm V; Podlech J; Thomas D; Deegen P; Pahl-Seibert MF; Lemmermann NA; Grzimek NK; Oehrlein-Karpi SA; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2008 Jun; 197(2):135-44. PubMed ID: 18340461
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
Front Immunol; 2021; 12():694588. PubMed ID: 34489940
[TBL] [Abstract][Full Text] [Related]
4. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
Lemmermann NA; Reddehase MJ
Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
[TBL] [Abstract][Full Text] [Related]
5. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
Reddehase MJ; Lemmermann NAW
Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.
Holtappels R; Becker S; Hamdan S; Freitag K; Podlech J; Lemmermann NA; Reddehase MJ
PLoS Pathog; 2023 Nov; 19(11):e1011643. PubMed ID: 37972198
[TBL] [Abstract][Full Text] [Related]
8. Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.
Maffini E; Giaccone L; Festuccia M; Brunello L; Busca A; Bruno B
Expert Rev Hematol; 2016 Jun; 9(6):585-96. PubMed ID: 27043241
[TBL] [Abstract][Full Text] [Related]
9. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
10. Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
Ebert S; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):541-50. PubMed ID: 22976556
[TBL] [Abstract][Full Text] [Related]
11. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
[TBL] [Abstract][Full Text] [Related]
12. Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.
Ebert S; Podlech J; Gillert-Marien D; Gergely KM; Büttner JK; Fink A; Freitag K; Thomas D; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):527-39. PubMed ID: 22972232
[TBL] [Abstract][Full Text] [Related]
13. Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.
Holtappels R; Podlech J; Freitag K; Lemmermann NA; Reddehase MJ
Viruses; 2022 May; 14(6):. PubMed ID: 35746617
[TBL] [Abstract][Full Text] [Related]
14. Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy.
Stemberger C; Graef P; Odendahl M; Albrecht J; Dössinger G; Anderl F; Buchholz VR; Gasteiger G; Schiemann M; Grigoleit GU; Schuster FR; Borkhardt A; Versluys B; Tonn T; Seifried E; Einsele H; Germeroth L; Busch DH; Neuenhahn M
Blood; 2014 Jul; 124(4):628-37. PubMed ID: 24855206
[TBL] [Abstract][Full Text] [Related]
15. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.
Steffens HP; Kurz S; Holtappels R; Reddehase MJ
J Virol; 1998 Mar; 72(3):1797-804. PubMed ID: 9499030
[TBL] [Abstract][Full Text] [Related]
16. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
[TBL] [Abstract][Full Text] [Related]
17. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.
Holtappels R; Simon CO; Munks MW; Thomas D; Deegen P; Kühnapfel B; Däubner T; Emde SF; Podlech J; Grzimek NK; Oehrlein-Karpi SA; Hill AB; Reddehase MJ
J Virol; 2008 Jun; 82(12):5781-96. PubMed ID: 18367531
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
Fleming T; Dunne J; Crowley B
J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
Jeitziner SM; Walton SM; Torti N; Oxenius A
Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
[TBL] [Abstract][Full Text] [Related]
20. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.
Peggs KS; Verfuerth S; Pizzey A; Khan N; Guiver M; Moss PA; Mackinnon S
Lancet; 2003 Oct; 362(9393):1375-7. PubMed ID: 14585640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
